AI brief of an SEC Form 8-K · Agilent Technologies (A)

Agilent adds Pascal Soriot and Judy Gawlik Brown to board; board expands to 12

Neutral Impact 3 of 5 leadership Written later

Agilent increased its board from 10 to 12 members and appointed Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder of Downtown Advisory and former Perrigo CFO, to fill the new seats. The company also amended its bylaws to remove an 80% voting-power requirement for certain actions, and director Heidi Kunz retired after more than 20 years of service.

Key points

  • Board size increased from 10 to 12; Pascal Soriot and Judy Gawlik Brown appointed effective May 20, 2025 per the 8-K, and May 21, 2025 per the press release
  • Soriot has been AstraZeneca CEO since October 2012; Brown was Perrigo CFO until February 2017
  • Amended bylaws eliminate the 80% affirmative vote requirement in Article IX for certain actions
  • Heidi Kunz retired from the board effective May 21, 2025, after joining in 2000

The filing

CompanyAgilent Technologies (A)
Form8-K, current report
Filed with the SECMay 21, 2025, 9:00 AM ET
Accession number0000950170-25-075587

Items reported: 5.02 Director / Officer Change5.03 Bylaw / Charter Amendment7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:42 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 21, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.